“The U.S. Food and Drug Administration has expanded the authorized use of Celgene Corp's cancer drug Revlimid to include newly diagnosed patients with multiple myeloma, the company said on Wednesday. Previously the drug was only approved for patients who had received at least one previous therapy.
“The U.S. Food and Drug Administration has expanded the authorized use of Celgene Corp's cancer drug Revlimid to include newly diagnosed patients with multiple myeloma, the company said on Wednesday. Previously the drug was only approved for patients who had received at least one previous therapy.
このブックマークにはスターがありません。
最初のスターをつけてみよう！
FDA approves new use for Celgene's cancer drug Revlimid
1 人がブックマーク・1 件のコメント
＼ コメントが サクサク読める アプリです ／